लोड हो रहा है...

Docetaxel for the Treatment of Hormone-Refractory Prostate Cancer

Chemotherapy has historically proven toxic and ineffective for the treatment of metastatic hormone-refractory prostate cancer (HRPC), a disease with substantial morbidity and mortality. Progress has been made in symptom relief, and the combination of mitoxantrone and prednisone is considered the pal...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखक: Petrylak, Daniel P
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MedReviews, LLC 2003
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC1502327/
https://ncbi.nlm.nih.gov/pubmed/16986041
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!